NCT03868124 - Clinical Study Comparing Two Models of a Travoprost Intraocular Implant | Biotech Hunter

Enrollment

560

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

June 10, 2022

Study Completion Date

June 19, 2024

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

COMBINATION_PRODUCT

G2-TR intraocular implant containing travoprost

Provided in Arm/Group descriptions

DRUG

Sham surgery + active-comparator eye drops

Sham surgery plus postoperative active-comparator eye drops (Timolol Maleate ophthalmic solution, 0.5%)

Trial Locations (1)

Center for Sight, Las Vegas